A Conversation with Dr. D. Benjamin Christie - Excerpt on Cases

Author: Harold M. Hastings, PhD, Co-Founder and Chief Technology Officer
Facility: ImaCor Inc. Garden City, NY

When you should use the hTEE probe - Sometimes, always, never? (“Never say never”)

Author: Harold M. Hastings, PhD, Co-Founder and Chief Technology Officer
Facility: ImaCor Inc. Garden City, NY
Summary: We report on user experience with “when you should use the hTEE probe” to optimize cardiac performance in several key areas of intensive care, ranging from some of the most complex patients in the ICU – patients with mechanical circulatory support to significantly less complex patients – patients fast-tracked after routine AVR. Disclaimer – hospital protocols and physician decisions determine patient selection and hTEE usage; we simply report on user experience.

A Conversation with Dr. D. Benjamin Christie

Author: Harold M. Hastings, PhD, Co-Founder and Chief Technology Officer
Facility: ImaCor Inc. Garden City, NY
Summary: Dudley Benjamin Christie, III, M.D. is Assistant Professor of Surgery, Departments of Surgery and Trauma/Critical Care at the Mercer University School of Medicine and Medical Center of Central Georgia in Macon, GA, USA. Dr. Christie uses hTEE extensively in managing trauma and acute care patients.

hTEE guides management of hemodynamic instability post MVR. A conversation with James E. Davies, Jr., MD, Assistant Professor of Surgery, Assistant Program Director for Thoracic Surgery, University of Alabama Birmingham

Author: Harold M. Hastings, PhD, Co-Founder and Chief Technology Officer
Facility: ImaCor Inc. Garden City, NY
Summary: Today, we all hope and expect to not only live longer than our parents, but to remain active and enjoy excellent health in our later years. This goal is becoming a reality more and more often, thanks in large part to today’s leading surgeons and physicians. In fact, these leaders have made cardiac surgery among the very elderly “almost routine,” “almost” since cardiac surgery in the elderly poses special challenges and risks, and “routine” since we frequently see good outcomes once these challenges are overcome. The present case illustrates the use of hTEE in determining the cause of hemodynamic instability in a ninety one year old female following mitral valve replacement, and guiding the physician’s management of hemodynamic instability towards resolution and a good outcome.

Newsday Article, Aug 2013: Cost-benefit prognosis: pitching probe's medical, economic value to hospitals

Author: Nicole Levy, Newsday
Summary: Dr. Scott L. Roth, co-founder and chief medical officer of ImaCor, demonstrates how the probe that his company developed to monitor a patient's heart for up to 72 hours, solves a problem common in the intensive care unit and is economically efficient.

(Almost) Everything You Wanted to Know About hTEE: The Evidence Speaks

Author: Harold M Hastings, PhD Co-Founder and CTO
Facility: ImaCor Inc. Garden City, NY
Summary: 2013 has been a great year for clinical evidence

Four articles in high-impact, peer-reviewed publications presented the clinical benefits of hTEE in almost 200 high-risk patients.

TJU Team Publishes ECMO Weaning Protocol – The Fourth hTEE Study in a High Impact Journal This Year

Author: Harold M. Hastings, PhD, Co-Founder and Chief Technology Officer
Facility: ImaCor Inc. Garden City, NY
Summary: A new and highly successful protocol for weaning ECMO developed by a team of leading critical care physicians at Thomas Jefferson University Hospital (Philadelphia, PA, US) - Drs. Nicholas C. Cavarocchi, Harrison T. Pitcher, Qiong Yang, Hitoshi Hirose - [1] was recently published in the Journal of Thoracic and Cardiovascular Surgery.